Abstract
Chemotherapy-induced peripheral neuropathy (CIPN) includes negative sensations that remain a major chronic problem for cancer survivors. CIPN is a common consequence of cancer and its treatments, where sensory nerves, motor nerves, and autonomic nerves can be affected, such that daily activities such as driving a car, putting on clothing, using utensils, and walking can become difficult if not impossible. Prior research found neurofeedback (a closed-loop brain-computer interface; BCI) was effective at treating CIPN versus a wait-list control (WLC). Our a-priori hypothesis was that BCI is superior to placebo feedback (PLC) and to a (WLC) in alleviating CIPN and that changes in brain activity would predict symptom report.
Poster presentation.